Ingevity Corp makes specialty chemicals and engineered materials that purify, protect, and enhance industrial and consumer products. Its portfolio spans activated carbon for emissions control, pavement technologies for asphalt and road markings, and caprolactone-based specialty polymers used in coatings, elastomers, adhesives, bioplastics, and medical applications.
45,0 %
39,5 %
−14,3 %
−17,0 %
1.33
0.79
| % | |
|---|---|
| Performance Materials | 45% Activated carbon and related materials used in emissions control and other high-specification applications. |
| Performance Chemicals / Pavement Technologies | 35% Chemistries and additives used in asphalt paving, road technologies, and road markings. |
| Advanced Polymer Technologies | 20% Caprolactone and caprolactone-based specialty polymers sold into coatings, elastomers, adhesives, and medical uses. |
Ingevity sells primarily to industrial customers, infrastructure-related buyers, and formulators that need...
Buy activated carbon materials used in gasoline vapor emissions control systems because they must meet strict emissions standards.
Paving contractors, asphalt producers, and related infrastructure customers buy additives and technologies to improve road durability and performance.
Government agencies and private contractors buy thermoplastic and waterborne road marking systems for long-life visibility and adhesion.
Coatings, resins, elastomers, adhesives, bioplastics, and medical customers buy caprolactone-based polymers for performance properties.
Ingevity sells globally, with customers in about 70 countries and non-U.S. sales representing roughly 43% of total...
Management is simplifying the portfolio toward two core businesses: Performance Materials and Pavement Technologies...
Management wants a more focused business mix with stronger and more consistent profitability.
The company is targeting a more stable specialty materials portfolio with best-in-class EBITDA margins.
Ingevity is emphasizing businesses aligned with its chemistry and engineered-materials expertise.
The business is exposed to customer concentration, cyclical industrial demand, and execution risk around portfolio...
A small number of customers account for a meaningful share of sales in some product lines, so lost business can quickly reduce revenue.
Planned divestitures or alternatives may not close, may be delayed, or may not deliver the expected margin improvement.
The company depends on third-party transportation and supplier networks for raw materials and product delivery.
Weaker demand or higher discount rates can reduce fair value and trigger non-cash charges.
A large share of sales is outside the U.S., creating currency, regulatory, and repatriation risk.
: 28.4.2026